Obesity in the elderly: peculiarities of treatment in outpatient practice
https://doi.org/10.14341/omet12919
Abstract
Today there is a worldwide trend of population aging, in addition, the proportion of older people with obesity is increasing. In order to adequately manage these patients in the outpatient setting, it is critical to understand the dynamic relationship between body weight, chronic disease prevalence, development of functional disability, life expectancy, and health care costs. While the obesity epidemic has affected people of all age groups, empirical knowledge about the management of obese older people remains largely scarce. Currently, there is no single therapeutic approach to this problem. Weight loss should be treated with caution in people over 60 years of age. The risk of sarcopenia, malnutrition, bone loss, increased risk of falls and injury must be considered, which can lead to an increase in the number of people with disabilities and the associated costs of medical and social care. The analytical review focuses on the relationship between two of the greatest epidemiological trends: aging and obesity. This paper highlights the features of the pathophysiology of obesity in the elderly, the phenomenon of the «obesity paradox». Also from the perspective of evidence-based medicine approaches to the treatment of obesity in the elderly, including surgical interventions aimed at reducing body weight, are analyzed.
About the Authors
L. A. Suplotova
Tyumen State Medical University
Russian Federation
Russian Federation
Lyudmila А. Suplotova, MD, PhD
54 Odesskaya st., 625023, Tyumen
O. O. Alieva
Tyumen State Medical University
Russian Federation
Russian Federation
Oksana O. Alieva
Tyumen
T. S. Dushina
Tyumen State Medical University
Russian Federation
Russian Federation
Tatiana S. Dushina
Tyumen
O. B. Makarova
Tyumen State Medical University
Russian Federation
Russian Federation
Olga B. Makarova, MD, PhD
Tyumen
References
1. World Health Organization (WHO) [Internet]. Fact sheets/Detail/ Ageing and health, 4 Oct. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/10-facts-on-ageing-and-health
2. World Obesity Atlas, March 2022 [Internet]. Available from: https://www.worldobesityday.org/assets/downloads/World_Obesity_Atlas_2022_WEB.pdf
3. McKee AM, Morley JE. Obesity in the Elderly. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText. com, Inc.; 2021.
4. Dedov II, Shestakova MV, Melnichenko GA, et al. Interdisciplinary clinical practice guidelines «Management of obesity and its comorbidities». Obesity and metabolism. 2021;18(1):5-99. (In Russ.)]. doi: https://doi.org/10.14341/omet12714
5. Osadchuk AM, Loranskaya ID, Osadchuk MA. Obesity and cancer. Two sides of the same problem. Profil meditsina. 2021;24(8):95-100. (In Russ.)]. doi: https://doi.org/10.17116/profmed20212408195
6. Bucholz EM, Beckman AL, Krumholz HA, Krumholz HM. Excess weight and life expectancy after acute myocardial infarction: The obesity paradox reexamined. Am Heart J. 2016;172:173-181. doi: https://doi.org/10.1016/j.ahj.2015.10.024
7. Tkacheva ON, Kotovskaya YuV, Runikhina NK, et al. Clinical guidelines on frailty. Russian Journal of Geriatric Medicine. 2020;(1):11-46. (In Russ.)]. doi: https://doi.org/10.37586/2686-8636-1-2020-11-46
8. Aleksanyan YaN, Mileeva LV. The prevalence of obesity in elderly patients with senile asthenia syndrome. Smolenskii meditsinskii al’manakh. 2020;(1):14-16. (In Russ.)].
9. Simbirtseva AS, Bylova NA, Arutyunov AG, et al. Prognostic role of body composition in patients with pneumonia associated with decompensated CHF. Kardiologiia. 2017;57(2S):343-350. (In Russ.)]. doi: https://doi.org/10.18087/cardio.2392
10. Donini LM, Pinto A, Giusti AM, et al. Obesity or BMI Paradox? Beneath the Tip of the Iceberg. Front Nutr. 2020;(7):53. doi: https://doi.org/10.3389/fnut.2020.00053
11. Trestini I, Carbognin L, Bonaiuto C, et al. The obesity paradox in cancer: clinical insights and perspectives. Eat Weight Disord. 2018;23(2):185-193. doi: https://doi.org/10.1007/s40519-018-0489-y
12. Caan BJ, Cespedes Feliciano EM, Kroenke CH. The importance of body composition in explaining the overweight paradox in cancer-counterpoint. Cancer Res. 2018;78(8):1906-1912. doi: https://doi.org/10.1158/0008-5472.CAN-17-3287
13. Flegal KM, Ioannidis JPA. The obesity paradox: A misleading term that should be abandoned. Obesity. 2018;26(4):629-630. doi: https://doi.org/10.1002/oby.22140
14. Park Y, Peterson LL, Colditz GA. The plausibility of obesity paradox in cancer-point. Cancer Res. 2018;78(8):1898-1903. doi: https://doi.org/10.1158/0008-5472.CAN-17-3043
15. Spelta F, Fratta Pasini AM, Cazzoletti L, et al. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord. 2018;23(1):15-22. doi: https://doi.org/10.1007/s40519-017-0456-z
16. Kim TN. Elderly obesity: Is it harmful or beneficial? J Obes Metab Syndr. 2018;27(2):84-92. doi: https://doi.org/10.7570/jomes.2018.27.2.84
17. Ji T, Li Y, Ma L. Sarcopenic obesity: An emerging public health problem. Aging Dis. 2022;13(2):379. doi: https://doi.org/10.14336/AD.2021.1006
18. El Bizri I, Batsis JA. Linking epidemiology and molecular mechanisms in sarcopenic obesity in populations. Proc Nutr Soc. 2020;79(4):448-456. doi: https://doi.org/10.1017/S0029665120000075
19. Roh E, Choi KM. Health consequences of sarcopenic obesity: A narrative review. Front Endocrinol (Lausanne). 2020;11(4):448-456. doi: https://doi.org/10.3389/fendo.2020.00332
20. Hong S, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. Int J Mol Sci. 2020;21(2):494. doi: https://doi.org/10.3390/ijms21020494
21. Lim H-S, Park Y-H, Suh K, et al. Association between sarcopenia, sarcopenic obesity, and chronic disease in Korean elderly. J Bone Metab. (2018) 25:187–93. doi: 10.11005/jbm.2018.25.3.187
22. Drapkina OM, Kim OT. Is brown adipose tissue a new target for obesity therapy? Cardiovascular Therapy and Prevention. 2021;20(5):2860. (In Russ.)]. doi: https://doi.org/10.15829/1728-8800-2021-2860
23. Zoico E, Rubele S, De Caro A, et al. Brown and beige adipose tissue and aging. Front Endocrinol (Lausanne). 2019;10(2):494. doi: https://doi.org/10.3389/fendo.2019.00368
24. Wang M, Tan Y, Shi Y, et al. Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments. Front Endocrinol (Lausanne). 2020;11. doi: https://doi.org/10.3389/fendo.2020.00568
25. Mathus-Vliegen EMH, Basdevant A, Finer N, et al. Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: A guideline. Obes Facts. 2012;5(3):460-483. doi: https://doi.org/10.1159/000341193
26. Sajoux I, Bellon A, Vidal J. Challenges in treatment of obesity in the elderly. Endocrinol Metab Int J. 2017;5(5):291-297. doi: https://doi.org/10.15406/emij.2017.05.00135
27. Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549-1564. doi: https://doi.org/10.1161/CIRCRESAHA.119.315896
28. Seo MH, Lee WY, Kim SS, et al. 2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea [published correction appears in J Obes Metab Syndr. 2019;28(2):143]. J Obes Metab Syndr. 2019;28(1):40-45. doi: https://doi.org/10.7570/jomes.2019.28.1.40
29. US Department of Agriculture and US [Internet]. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9th Edition. [cited December 2020]. Available from: https://www.dietaryguidelines.gov/
30. Prokopidis K, Cervo MM, Gandham A, et al. Impact of protein intake in older adults with sarcopenia and obesity: A gut microbiota perspective. Nutrients. 2020;12(8):2285. doi: https://doi.org/10.3390/nu12082285
31. Drapkina OM, Samorodskaya IV, Starinskaya MA, et al. Ozhirenie: otsenka i taktika vedeniya patsientov. Kollektivnaya monografiya. Moscow: OOO “Silitseya-Poligraf”; 2021. (In Russ.)].
32. Report of the Scientific Committee of the Food Safety Authority of Ireland. Scientific Recommendations for Food-based Dietary Guidelines for Older Adults in Ireland. 2021.
33. Dedov II, Melnichenko GA, Belaya JE, et al. Vitamin D deficiency in adults. Clinical recommendations. Moscow: Russian Association of Endocrinologists; 2016. (In Russ.)]
34. Verlaan S, Maier AB, Bauer JM, et al. Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults – The PROVIDE study. Clin Nutr. 2018;37(2):551-557. doi: https://doi.org/10.1016/j.clnu.2017.01.005
35. Wharton S, Lau DCW, Vallis M, et al. Obesity in adults: a clinical practice guideline. Can Med Assoc J. 2020;192(31):E875-E891. doi: https://doi.org/10.1503/cmaj.191707
36. Sherrington C, Fairhall NJ, Wallbank GK, et al. Exercise for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2019;1(1):CD012424. doi: https://doi.org/10.1002/14651858.CD012424.pub2
37. Physical Activity Guidelines Advisory Committee Scientific Report. Washington, DC: US Department of Health and Human Services; 2018.
38. Sherrington C, Fairhall N, Kwok W, et al. Evidence on physical activity and falls prevention for people aged 65+ years: systematic review to inform the WHO guidelines on physical activity and sedentary behaviour. Int J Behav Nutr Phys Act. 2020;17(1):144. doi: https://doi.org/10.1186/s12966-020-01041-3
39. de Souto Barreto P, Rolland Y, Vellas B, Maltais M. Association of long-term exercise training with risk of falls, fractures, hospitalizations, and mortality in older adults: A systematic review and meta-analysis. JAMA Intern Med. 2019;179(3):394-405. doi: https://doi.org/10.1001/jamainternmed.2018.5406
40. Bueno de Souza RO, Marcon LF, Arruda ASF, et al. Effects of mat pilates on physical functional performance of older adults: A meta-analysis of randomized controlled trials. Am J Phys Med Rehabil. 2018;97(6):414-425. doi: https://doi.org/10.1097/PHM.0000000000000883
41. WHO [Internet]. Guidelines On Physical Activity And Sedentary Behavior 2020 [cited 09.06.2023]. Available from: https://www.who.int/publications-detail-redirect/9789240015128
42. Izquierdo M, Merchant RA, Morley JE, et al. International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines. J Nutr Health Aging. 2021;25(7):824-853. doi: https://doi.org/10.1007/s12603-021-1665-8
43. Veronese N, Stubbs B, Volpato S, et al. Association between gait speed with mortality, cardiovascular disease and cancer: A systematic review and meta-analysis of prospective cohort studies. J Am Med Dir Assoc. 2018;19(11):981-988.e7. doi: https://doi.org/10.1016/j.jamda.2018.06.007
44. Ingold M, Tulliani N, Chan CCH, et al. Cognitive function of older adults engaging in physical activity. BMC Geriatr. 2020;20(1):229. doi: https://doi.org/10.1186/s12877-020-01620-w
45. Orringer KA, Van Harrison R, Nichani SS, et al. Obesity Prevention and Management. Ann Arbor (MI): Michigan Medicine University of Michigan; 2021.
46. Dedov II, Mokrysheva NG, Melnichenko GA, et al. Obesity. Clinical recommendations. Moscow: Russian Association of Endocrinologists; 2020. 43 p. (In Russ.)].
47. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi: https://doi.org/10.1056/NEJMoa2032183
48. Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA. 2021;325(14):1414-1425. doi: https://doi.org/10.1001/jama.2021.3224
49. Yabe D, Shiki K, Suzaki K, et al. Rationale and design of the EMPAELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodiumglucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes. BMJ Open. 2021;11(4):e045844. doi: https://doi.org/10.1136/bmjopen-2020-045844
50. Anisimova KA, Davletbaevа LI, Balandov SG, et al. Evaluation of risk factors for bariatric surgery in elderly patients with morbid obesity. The Scientific Notes of the Pavlov University. 2021;28(4):81-85. (In Russ.)]. doi: https://doi.org/10.24884/1607-4181-2021-28-4-81-85
51. Pechman DM, Muñoz Flores F, Kinkhabwala CM, et al. Bariatric surgery in the elderly: outcomes analysis of patients over 70 using the ACS-NSQIP database. Surg Obes Relat Dis. 2019;15(11):1923-1932. doi: https://doi.org/10.1016/j.soard.2019.08.011
52. Nevo N, Eldar SM, Lessing Y, et al. Sleeve gastrectomy in the elderly. Obes Facts. 2019;12(5):502-508. doi: https://doi.org/10.1159/000502697
53. Susmallian S, Raziel A, Barnea R, Paran H. Bariatric surgery in older adults: Should there be an age limit? Medicine (Baltimore). 2019;98(3):e13824. doi: https://doi.org/10.1097/MD.0000000000013824
54. Iranmanesh P, Boudreau V, Ramji K, et al. Outcomes of bariatric surgery in elderly patients: a registry-based cohort study with 3-year follow-up. Int J Obes (Lond). 2022;46(3):574-580. doi: https://doi.org/10.1038/s41366-021-01031-w
55. Durrer Schutz D, Busetto L, Dicker D, et al. European practical and patient-centred guidelines for adult obesity management in primary care. Obes Facts. 2019;12(1):40-66. doi: https://doi.org/10.1159/000496183
56. Leskova IV, Mazurina NV, Troshina EA, et al. Social and medical aspects of elderly age: obesity and professional longevity. Obesity and metabolism. 2017;14(4):10-15. (In Russ.)]. doi: https://doi.org/10.14341/omet2017410-15
Supplementary files
|
|
1. Figure 1. Etiology and pathogenesis of sarcopenic obesity (adapted from Tong Ji et al., 2022) | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(603KB)
|
Indexing metadata ▾ | |
Review
For citations:
Suplotova L.A., Alieva O.O., Dushina T.S., Makarova O.B. Obesity in the elderly: peculiarities of treatment in outpatient practice. Obesity and metabolism. 2023;20(2):140-148. (In Russ.) https://doi.org/10.14341/omet12919
Views:
5880
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
